Neuro-Partnerships Program

The Neuro-Partnerships Program envelope of $3.1 million is available until 2023. Under this program, Healthy Brains, Healthy Lives (HBHL) provides 1:1 matching funds for projects with a high potential impact on biopharmaceutical research through existing programs offered by the Ministère de l'Économie et de l'Innovation (MEI). Co-funding is available for up to 40% of the total project cost. MEI co-funding is available through CQDM Quantum Leap and SynergiQc programs; and the MEDTEQ Industrial Consortium for Research and Innovation in Medical Technologies. Read more about this program and the evaluation process.

Theme Principal Investigator MEI partner  Other partners Project title

Funding received

2 Brian Chen CQDM-Quantum Leap

The Research Institute of the McGill University Health Centre (RI-MUHC)

Brain Canada

A drug-screening platform to increase protein expression levels for the treatment of neurological disorders.

Total: $1,495,789

HBHL: $580,000

2 Philippe Gros CQDM-SynergiQc

Corbin Therapeutics

Brain Canada

Exploitation of a new pharmacological target for the development and validation of new anti-inflammatory drugs.

Total: $1,582,821

HBHL: $550,000

3 Alain Ptito MEDTEQ-Impact

Saccade Analytics

Fondation NeuroTrauma Marie-Robert

Mitacs

Advanced Nystagmus System (ANS™) as objective diagnostic tool for mild traumatic brain injury (mTBI) and concussion: A validation

study using structural and functional magnetic resonance imaging.

Total: $216,377

HBHL: $51,322

2 Jean-Paul Soucy MEDTEQ-Impact

Optina Diagnostics

Mitacs

Collaborative Health Research Projects

Evaluation of a radiomic approach based on hyperspectral retinal imaging to predict the cerebral amyloid status for the diagnosis of Alzheimer’s disease.

Total: $881,578

HBHL: $208,757

1 Manuela Ferrari (previously, Outi Linnaranta) MEDTEQ-Impact

Aifred Health

Douglas Hospital

Implementation of a digital mental health tool in an Urban and Rural Setting – Optimizing Usability and Data Quality.

Total: $88,104

HBHL: $21,000

1 Yasser Iturria-Medina MEDTEQ-Impact

Arctic Fox AI

MGH Foundation

Data-driven Biomarker Based Alzheimer’s Disease Progression Composite Score.

Total: $120,498

HBHL: $42,000

2 David Juncker CQDM-Quantum Leap Nplex Biosciences The 200-plex nano-ELISA: a next-generation immuno-proteomic technology for biomarker and drug discovery.

Total: $845,484

HBHL: $200,000

2 Thomas Durcan CQDM-Quantum Leap Brain Canada Development of a high throughput 3D microphysiological platform for rapid automated assessment of human brain organoids response to drugs targeting neurological disorders.

Total: $1,755,736

HBHL: $600,000

1 Blake Richards MEDTEQ-Impact

Mitacs

Bios Santé

Development of an AI-controlled closed-loop neuromodulation system for chronic conditions

Total: $392,647

HBHL:
$65,580

2 Thomas Durcan CQDM-SynergiQc

Raya Therapeutique

Eikonizo Therapeutics

The preclinical development of 5 molecules for Amyotrophic Lateral Sclerosis and other neurodegenerative

Total: $1,938,890

HBHL: $200,000

Back to top